2013 NCCN Oncology Curriculum: Metastatic Colorectal Cancer
As research continues and new information emerges in the area of metastatic colorectal cancer, it is critical that clinicians are kept up-to-date and informed. To ensure that oncologists have a clear understanding of the most up-to-date treatment recommendations for metastatic colorectal cancer as well as emerging treatment options, NCCN is conducting a series of educational activities collectively known as the NCCN Oncology Curriculum: Metastatic Colorectal Cancer. This series of activities communicates current and emerging treatment options in a direct and interactive way in order to improve knowledge and help clinicians understand how to apply this information in their practice setting.
The curriculum consists of multiple educational offerings in a variety of educational formats in order to best meet learner needs. The goal of this curriculum is to educate participants about the current and emerging treatment options, including safety, efficacy, and mechanisms of action.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits may also be provided. Please refer to the complete accreditation information provided before each individual educational activity for more details.
There is no fee for these activities.
Supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Genentech, USA; Lilly USA, LLC; and sanofi-aventis U.S. and Regeneron Pharmaceuticals